What Is Cluster Headache? Symptoms, Causes and Treatment

Cluster headache is among the most severe pain conditions in medicine, yet it remains widely misdiagnosed and misunderstood. If you — or someone you know — experiences attacks of extreme, one-sided head pain centred around the eye, accompanied by autonomic symptoms and intense restlessness, cluster headache may be the explanation. This article explains what it is, what causes it, and what the evidence says about treatment.

What is cluster headache?

Cluster headache (CH) is a primary headache disorder — a condition in its own right, not caused by an underlying disease. It is the most common of a group called trigeminal autonomic cephalalgias (TACs) — headache disorders involving both pain and automatic nervous system responses on one side of the face (ICHD-3). Despite this classification, CH affects fewer than 1% of the population, with a lifetime prevalence of approximately 124 per 100,000 (Malu et al., American Family Physician, 2022).

The condition is two to three times more common in men than women, with a mean age of onset of around 30 years (Malu et al., 2022). Having a first-degree relative with cluster headache increases risk by 5 to 18 times, indicating a strong genetic component (Malu et al., 2022). Despite its distinct clinical features, cluster headache is frequently misdiagnosed — patients are often seen by dentists or ENT specialists before receiving a correct neurological diagnosis, and diagnostic delays of years are common (Wei et al., Frontiers in Neurology, 2024).

The impact on quality of life is severe. People with cluster headache experience high rates of depression and, during active bout periods, significantly elevated rates of suicidal ideation — a reflection of both the intensity of pain and the unpredictability of attacks (Wei et al., 2024). Early, accurate diagnosis matters enormously.

The two types: episodic and chronic

ICHD-3 classifies cluster headache into two forms based on the pattern of bouts (periods of active attacks) and remissions.

• Episodic cluster headache — bouts last between 7 days and 1 year, separated by pain-free remission periods of at least 3 months. This is the more common form.
• Chronic cluster headache — attacks continue for more than 1 year without a remission period of 3 months or longer, or remissions last fewer than 3 months (ICHD-3).

A defining feature of cluster headache is its circadian and circannual rhythmicity — attacks tend to occur at predictable times of day (often in the early hours of the morning) and cluster periods often occur at the same time each year, frequently in spring or autumn. This regularity is thought to involve the hypothalamus and the brain's internal clock mechanism (suprachiasmatic nucleus) (Mitsikostas et al., European Journal of Neurology, 2023).

People can shift between episodic and chronic forms over time. Longitudinal data suggest cluster headache tends to remit with age in many — though not all — patients (Malu et al., 2022).

What does a cluster headache attack feel like?

Cluster headache attacks are characterised by their extraordinary severity and distinctive combination of features. ICHD-3 diagnostic criteria require all of the following:

Pain characteristics:

• Severe or very severe intensity
• Strictly unilateral — always on the same side, centred in the orbital (around the eye), supraorbital (above the eye), and/or temporal region
• Duration: 15 to 180 minutes without treatment
• Frequency: from every other day up to 8 attacks per day

Associated features — at least one must be present on the same side as the pain:

• Lacrimation (watering eye)
• Conjunctival injection (redness of the eye)
• Nasal congestion or rhinorrhoea (blocked or running nostril)
• Ptosis (drooping eyelid)
• Eyelid oedema
• Forehead or facial sweating
• Miosis (constricted pupil)

A sense of agitation or restlessness is a key and highly characteristic feature of cluster headache. Unlike migraine — where lying still in a dark room brings relief — people with cluster headache typically pace, rock, or cannot remain still during an attack. This feature, if present, should always be explored in the clinical history (Malu et al., 2022).

The pain is frequently described as boring, piercing, or burning — located deep behind the eye. Many patients describe it as the worst pain they have ever experienced. The informal term "suicide headache" reflects the severity that some patients report, particularly during chronic phases.

What causes cluster headache?

The precise pathophysiology of cluster headache is not yet fully understood, but research has substantially advanced our knowledge. Three interacting systems are implicated (Vollesen et al., Brain and Behavior, 2021):

1. The trigeminovascular system — activation of the trigeminal nerve and its connections generates the severe unilateral pain.
2. The trigeminal autonomic reflex — a reflex arc connecting the trigeminal nerve to the facial parasympathetic (autonomic) system, producing the characteristic ipsilateral autonomic symptoms.
3. The hypothalamus — the circadian and circannual rhythmicity of cluster headache strongly implicates the posterior hypothalamus as a central driver of bouts. Neuroimaging studies have shown hypothalamic activation during attacks, and structural differences in the hypothalamus have been documented in people with cluster headache (Yang et al., Cephalalgia, 2017).

Calcitonin gene-related peptide (CGRP) — a neuropeptide involved in pain transmission — is released during cluster headache attacks and is a target of newer treatments (Robbins & Starling, Lancet Neurology, 2024).

Genetic factors are significant. Eight genetic loci associated with cluster headache have been identified through international collaboration, involving pathways related to neurovascular regulation, inflammation, and circadian biology (Robbins & Starling, 2024).

Common triggers during active cluster periods include:

• Alcohol (one of the most reliably reported triggers during bouts)
• Nitroglycerin and other vasodilating medications
• Foods containing nitrates
• Strong odours, including tobacco smoke and petroleum
• Histamine exposure

It is important to note that triggers typically only provoke attacks during a bout — alcohol, for example, does not trigger attacks in the out-of-bout period in most people (Malu et al., 2022).

How is cluster headache diagnosed?

Cluster headache is a clinical diagnosis based on history assessed against ICHD-3 criteria. At least five attacks meeting the criteria above are required for diagnosis. Neuroimaging is not routinely recommended unless SNOOP red flags are present (Malu et al., 2022).

The differential diagnosis includes other TACs — particularly paroxysmal hemicrania (shorter, more frequent attacks that respond to indomethacin) and SUNCT (short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing). Distinguishing between these conditions requires specialist assessment, as treatment differs significantly.

Cluster headache is frequently confused with migraine by clinicians unfamiliar with it. Key distinguishing features: migraine typically causes photophobia, phonophobia, and nausea, and patients prefer to lie still; cluster headache does not cause these features at the same level, and patients are agitated and restless rather than still.

HeadacheRecovery is a tracking and self-management tool, not a diagnostic service. If you suspect cluster headache, tracking the precise timing, duration, frequency, location, and associated symptoms of your attacks is the most useful preparation for a clinical consultation. The data you record directly maps to the diagnostic criteria your clinician uses.

Treatment: what the evidence shows

HeadacheRecovery is a non-pharmacological, tracking-based approach. The summary below is background context on what the research literature covers — it is not treatment advice, and no medicine, dose or device is recommended here. Treatment for cluster headache is prescribed and monitored by a doctor, ideally a headache specialist.

Research divides cluster headache treatment into three categories: acute (abortive) treatment for individual attacks, transitional treatment to bridge the gap while preventive treatment takes effect, and preventive (prophylactic) treatment to reduce or stop bouts.

Across all three categories, randomised controlled trials support several established options, and reviews of the evidence consistently conclude that cluster headache is treatable when it is correctly diagnosed (Malu et al., 2022; Mitsikostas et al., European Journal of Neurology, 2023; Robbins & Starling, Lancet Neurology, 2024). Some acute options work within minutes of an attack starting; short-term bridging treatments are used while a preventive treatment builds up; and preventive treatment aims to shorten or suppress the bout. Neuromodulation approaches also have trial evidence, including for people whose attacks do not respond to standard treatment.

Which of these is appropriate — and the dose, timing, monitoring and safety checks involved — depends on your medical history and other conditions, so it is a decision for your clinician. Do not start, stop or change any treatment on your own. What you can usefully bring to that conversation is an accurate record of your attacks: timing, duration, frequency, side, and associated symptoms.

Can exercise help?

A cross-sectional survey of 167 cluster headache patients found that approximately 40% had attempted exercise during attacks, and of those, 43% reported some improvement — with 30% achieving ≥50% reduction in attack intensity (Kim et al., PMC, 2025). High-intensity exercise (running, squats, stair climbing) was most commonly reported as effective. A small case series of physiotherapy combining manual therapy and exercise found 2 of 7 patients reduced attack frequency by over 50% (García-Azorín et al., PMC, 2021). Evidence is currently limited to small studies, and exercise should be considered a potential adjunct only — not a replacement for established medical treatment.

When to seek help